Sunshine Guojian Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 399 million yuan, a year-on-year increase of 71.15%

According to the Zhitong Finance APP, Sunshine Guojian Pharmaceutical disclosed its third-quarter report for 2025. The company achieved revenue of 1.116 billion yuan in the first three quarters, a year-on-year increase of 18.80%; the net profit attributable to shareholders of the listed company was 399 million yuan, a year-on-year increase of 71.15%; the net profit excluding non-recurring gains and losses was 352 million yuan, a year-on-year increase of 62.39%; and the basic earnings per share were 0.65 yuan